Gaviola, Phedilyn .
HRN: 15-71-24 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2023
CEFUROXIME 1.5GM (VIAL)
09/22/2023
09/24/2023
IV
1.5gms
Now Then Q8hrs
STAT CS
Checking Final Appropriateness
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes